Nykode Therapeutics Announces Expansion of Oncology Pipeline
https://newsweb.oslobors.no/message/606580
âI am thrilled about this exciting addition to our pipeline, which underscores Nykode's dedication to creating innovative solutions for an expanding range of patients in need of alternative therapies,â said Mikkel W. Pedersen, Nykodeâs Chief Scientific Officer. âAdditionally, it signifies our belief in the promise of cancer vaccines across all stages of cancer development."
âI am thrilled about this exciting addition to our pipeline, which underscores Nykode's dedication to creating innovative solutions for an expanding range of patients in need of alternative therapies,â said Mikkel W. Pedersen, Nykodeâs Chief Scientific Officer. âAdditionally, it signifies our belief in the promise of cancer vaccines across all stages of cancer development."
omvo
15.12.2023 kl 08:59
2800
This yearâs OSEBX portfolio is skewed towards industrials and healthcare. OSEBX portfolio. This yearâs portfolio consists of Aker Horizons, ArcticZymes, Elkem, Hexagon Purus, Kongsberg Automotive, Nel, Nordic Semiconductor, Nykode, Photocure, and Tomra.
Nykode er en av DNB's favoritter.
Nykode er en av DNB's favoritter.
omvo
19.12.2023 kl 08:28
2125
Regner med den J.P. Morgan-kontoen som har handlet nesten 3 millioner aksjer siden oktober tok imot bra med aksjer i gÄr.
Ny dag og nye muligheter i dag med melding om presentasjon pÄ J.P. Morgan Healthcare Conference 10.januar
Ny dag og nye muligheter i dag med melding om presentasjon pÄ J.P. Morgan Healthcare Conference 10.januar
Redigert 19.12.2023 kl 08:30
Du mÄ logge inn for Ä svare